Literature DB >> 33099450

Screening for Prostate Cancer.

Sigrid V Carlsson1, Andrew J Vickers2.   

Abstract

This article gives an overview of the current state of the evidence for prostate cancer early detection with prostate-specific antigen (PSA) and summarizes current recommendations from guideline groups. The article reviews the global public health burden and risk factors for prostate cancer with clinical implications as screening tools. Screening studies, novel biomarkers, and MRI are discussed. The article outlines 7 key practice points for primary care physicians and provides a simple schema for facilitating shared decision-making conversations.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomarkers; Magnetic resonance imaging; Prostate cancer; Prostate-specific antigen; Screening

Mesh:

Substances:

Year:  2020        PMID: 33099450     DOI: 10.1016/j.mcna.2020.08.007

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  14 in total

1.  Early Diagnosis of Lung Cancer: The Urgent Need of a Clinical Test.

Authors:  Roberto Gasparri; Alessandra Guaglio; Lorenzo Spaggiari
Journal:  J Clin Med       Date:  2022-07-28       Impact factor: 4.964

2.  New Insights into the Multivariate Analysis of SER Spectra Collected on Blood Samples for Prostate Cancer Detection: Towards a Better Understanding of the Role Played by Different Biomolecules on Cancer Screening: A Preliminary Study.

Authors:  Vlad Cristian Munteanu; Raluca Andrada Munteanu; Diana Gulei; Radu Mărginean; Vlad Horia Schițcu; Anca Onaciu; Valentin Toma; Gabriela Fabiola Știufiuc; Ioan Coman; Rareș Ionuț Știufiuc
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

3.  Expression status and prognostic value of autophagy-related lncRNAs in prostate cancer.

Authors:  Guo Chen; Xiaoping Qin; Yu Wang; Biyun Gao; Muan Ling; Wenjun Yin; Yutong Li; Bin Pan
Journal:  Cell Cycle       Date:  2022-04-24       Impact factor: 5.173

4.  βKlotho Inhibits Cell Proliferation by Downregulating ELK4 and Predicts Favorable Prognosis in Prostate Cancer.

Authors:  Changlin Mao; Wei Dong; Jiaju Lu; Zhao Zhang; Hongliang Wu; Armin Ghavamian; Dongbin Bi; Pei Gao; Zhao Liu; Sentai Ding
Journal:  Cancer Manag Res       Date:  2021-08-12       Impact factor: 3.989

5.  Development and Validation of Analytical Methods for Radiochemical Purity of 177Lu-PSMA-1.

Authors:  Pauline Orhon; Marie-Dominique Desruet; Marie Piquemal; Nicolas De Leiris; Loïc Djaileb; Jean-Philippe Vuillez; Pierrick Bedouch; Julien Leenhardt
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-24

6.  Impact on prostate cancer clinical presentation after non-screening policies at a tertiary-care medical center- a retrospective study.

Authors:  Tarek Ajami; Jaime Durruty; Claudia Mercader; Leonardo Rodriguez; Maria J Ribal; Antonio Alcaraz; Antoni Vilaseca
Journal:  BMC Urol       Date:  2021-02-08       Impact factor: 2.264

7.  Based on biomedical index data: Risk prediction model for prostate cancer.

Authors:  Hanxu Guo; Xianjie Jia; Hao Liu
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

Review 8.  Urinary Extracellular Vesicles as Potential Biomarkers for Urologic Cancers: An Overview of Current Methods and Advances.

Authors:  Catarina Lourenço; Vera Constâncio; Rui Henrique; Ângela Carvalho; Carmen Jerónimo
Journal:  Cancers (Basel)       Date:  2021-03-26       Impact factor: 6.639

9.  Screening to Identify an Immune Landscape-Based Prognostic Predictor and Therapeutic Target for Prostate Cancer.

Authors:  Yanting Shen; Huan Xu; Manmei Long; Miaomiao Guo; Peizhang Li; Ming Zhan; Zhong Wang
Journal:  Front Oncol       Date:  2021-11-05       Impact factor: 6.244

Review 10.  Molecular mechanisms and clinical applications of exosomes in prostate cancer.

Authors:  Xiaolin Cui; Qiang Fu; Xueying Wang; Pengcheng Xia; Xianglun Cui; Xiaohui Bai; Zhiming Lu
Journal:  Biomark Res       Date:  2022-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.